Market Size of Spain Contraceptive Devices Industry
Study Period | 2020 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2020 - 2022 |
CAGR | 7.90 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Spain Contraceptive Devices Market Analysis
The Spanish contraceptive device market is expected to register a 7.9% CAGR during the forecast period.
The COVID-19 pandemic had a significant impact on the contraceptive device market at first.The strict lockdowns and government regulations intended to slow down the spread of COVID-19 resulted in a decrease in access to contraceptive devices. Moreover, due to house confinement, sexual activities were notably reduced in the country. For instance, according to an article published by PubMed in May 2021, a survey was conducted on 1,407 women in Spain, and 53.5% of them responded that their sexual activity decreased during the pandemic. Furthermore, according to an article published by the Journal of Clinical Medicine in July 2022, the frequency of sexual relationships was reduced among women in Spain, and it was even lower in those who did not live with their partners during the pandemic. The article further stated that women in Spain faced difficulties accessing contraceptive methods during the pandemic, and these women belonged to the age group of 25 to 34 years. Thus, the COVID-19 outbreak affected the market's growth adversely in its preliminary phase; however, currently, the market has reverted back to the pre-pandemic phase, and it is expected to gain traction in the forecast period of the study.
Furthermore, the increasing prevalence of sexually transmitted diseases (STDs), increasing awareness about STDs, and rising government initiatives are among the major factors driving the growth of the studied market. Currently, people are extremely concerned about their sexual health, and awareness about the usage of contraceptive devices to prevent any STDs is increasing in the country. Such factors are likely to boost the adoption of contraceptive devices, thereby contributing to the studied market's growth. For instance, according to an article published by ScienceDirect in January 2022, the incidence of STDs in Spain has been growing in recent decades, and the number of gonococcal infections per 100,000 persons continues to increase every year in the country. Therefore, the increasing prevalence of STDs in the country will boost the adoption of contraceptive devices, and hence, the studied market is expected to experience growth in the future.
In addition, the rising initiatives by the government of Spain are positively affecting the growth of the studied market. For instance, according to the Council of Ministers of Spain in May 2022, the Government of Spain reformed the law regarding sexual and reproductive health and the voluntary interruption of pregnancy and took new measures on sexuality education and contraception, menstrual health, pregnancy, childbirth, abortion, and reproductive violenceres on sexuality education and contraception, menstrual health, pregnancy, childbirth, abortion, and reproductive violence. It was also mentioned that guaranteed access to barrier methods of contraception will be distributed free of charge in high schools, prisons, and social service centers, and that public funding is also to be expanded and priority given to the latest generation of contraceptives in Spain. Moreover, the development and research of male contraception will also be promoted to encourage men's co-responsibility.
Therefore, owing to the aforementioned factors, such as the increasing prevalence of sexually transmitted diseases (STDs), increasing awareness about STDs, and rising government initiatives, the studied market is anticipated to witness growth over the analysis period. However, the side effects associated with the use of contraceptive devices are likely to impede the market's growth.
Spain Contraceptive Devices Industry Segmentation
As per the scope of the report, a contraceptive device is a device that prevents the entry of sperm into the uterus, and they are used for the intentional prevention of conception. The Spain Contraceptive Devices Market is expected to register a CAGR of 7.9% over the forecast period (2022-2027). The Spain contraceptive devices market is segmented by type (condoms, diaphragms, cervical caps, sponges, vaginal rings, intrauterine devices (IUD), and other types) and gender (male and female). The report offers the value (in USD million) for the above segments.
By Type | |
Condoms | |
Diaphragms | |
Cervical Caps | |
Sponges | |
Vaginal Rings | |
Intra Uterine Device (IUD) | |
Other Product Types |
By Gender | |
Male | |
Female |
Spain Contraceptive Devices Market Size Summary
The Spanish contraceptive device market is poised for significant growth, driven by a combination of increasing awareness about sexual health, the rising prevalence of sexually transmitted diseases, and proactive government initiatives. The market, which experienced a temporary setback due to the COVID-19 pandemic, has rebounded and is expected to continue its upward trajectory. The pandemic initially hindered access to contraceptive devices and reduced sexual activity, but these effects have subsided. The growing concern over STDs and the importance of contraceptive devices in prevention are key factors propelling market expansion. Government efforts, such as reforms in sexual and reproductive health laws and the provision of free barrier methods in educational and social institutions, further support this growth.
The market is characterized by a high level of consolidation, with a few major players like AbbVie, Bayer AG, and Teva Pharmaceutical Industries Ltd. dominating the landscape. The condom segment, in particular, is expected to see substantial growth due to its effectiveness in preventing STDs and its widespread adoption. Intrauterine devices (IUDs) are also gaining traction, supported by positive user satisfaction and government backing. The competitive environment is marked by strategic moves, such as Bayer AG's launch of an extended-use IUD and Perrigo Company's acquisition of HRA Pharma, which enhance the availability and variety of contraceptive options in Spain.
Spain Contraceptive Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Sexually Transmitted Diseases and Rising Awareness About Them
-
1.2.2 Rise in Government Initiatives
-
-
1.3 Market Restraints
-
1.3.1 Side Effects Associated with the Use of Contraceptive Devices
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Type
-
2.1.1 Condoms
-
2.1.2 Diaphragms
-
2.1.3 Cervical Caps
-
2.1.4 Sponges
-
2.1.5 Vaginal Rings
-
2.1.6 Intra Uterine Device (IUD)
-
2.1.7 Other Product Types
-
-
2.2 By Gender
-
2.2.1 Male
-
2.2.2 Female
-
-
Spain Contraceptive Devices Market Size FAQs
What is the current Spain Contraceptive Devices Market size?
The Spain Contraceptive Devices Market is projected to register a CAGR of 7.90% during the forecast period (2024-2029)
Who are the key players in Spain Contraceptive Devices Market?
AbbVie (Allergan PLC), Bayer AG, Cooper Surgical Inc., Reckitt Benckiser and Teva Pharmaceutical Industries Ltd are the major companies operating in the Spain Contraceptive Devices Market.